Activating HER2 mutations typically fall into four categories, with distribution dependent on tumor type: single nucleotide variants (SNVs) in the extracellular domain, particularly S310F/Y; SNVs in the transmembrane domain; SNVs in the kinase domain; and small insertions in exon 20[4,10,11]. Here, ERBB2 is linked to neoplasm.